Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Massonneau, Julie"'
Autor:
Stimmer, Lev, Confais, Joachim, Jong, Anke‘t, Veth, Jennifer, Fovet, Claire-Maëlle, Horellou, Philippe, Massonneau, Julie, Perrin, Audrey, Miotello, Guylaine, Avazeri, Emilie, Hart, Bert‘t, Deiva, Kumaran, Le Grand, Roger, Armengaud, Jean, Bajramovic, Jeffrey J., Contamin, Hugues, Serguera, Ché
Publikováno v:
In Laboratory Investigation November 2021 101(11):1513-1522
Autor:
Serguera, Che, Stimmer, Lev, Claire-Maelle Fovet, Horellou, Philippe, Contreras, Vanessa, Tchitchek, Nicolas, Massonneau, Julie, Leroy, Carole, Perrin, Audrey, Flament, Julien, Hantraye, Philippe, Demilly, Joanna, Marignier, Romain, Chrétien, Pascale, Bert‘T Hart, Boutonnat, Jean, Adam, Clovis, Le-Grand, Roger, Kumaran Deiva
Additional file 1: Table S1. Multiparameter comparison of EAE in macaques and human ADS. Table S2. Macaques involved in this study. Table S3. Disease evolution of children involved in this study. Table S4. Sites of lesions in patients MOG- vs. patien
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7bde25b37bc3a711ac4caee93298c1c9
Autor:
Fovet, Claire-Maëlle, Stimmer, Lev, Contreras, Vanessa, Horellou, Philippe, Hubert, Audrey, Seddiki, Nabila, Chapon, Catherine, Tricot, Sabine, Leroy, Carole, Flament, Julien, Massonneau, Julie, Tchitchek, Nicolas, 't Hart, Bert, Zurawski, Sandra, Klucar, Peter, Hantraye, Philippe, Deiva, Kumaran, Zurawski, Gérard, Oh, Sangkon, Le Grand, Roger, Serguera, Ché
Publikováno v:
EBioMedicine
EBioMedicine, Elsevier, 2019, 47, pp.492-505. ⟨10.1016/j.ebiom.2019.08.052⟩
EBioMedicine, 2019, 47, pp.492-505. ⟨10.1016/j.ebiom.2019.08.052⟩
EBioMedicine, Elsevier, 2019, 47, pp.492-505. ⟨10.1016/j.ebiom.2019.08.052⟩
EBioMedicine, 2019, 47, pp.492-505. ⟨10.1016/j.ebiom.2019.08.052⟩
International audience; BACKGROUND: Autoimmune demyelinating diseases (ADD) are a major cause of neurological disability due to autoreactive cellular and humoral immune responses against brain antigens. A cure for chronic ADD could be obtained by app
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::6219a26bffc0afaf9fc8c83aa5419a26
https://hal.sorbonne-universite.fr/hal-02305565
https://hal.sorbonne-universite.fr/hal-02305565
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Guigand, Lydie, Ledevin, Mireille, Fernandez, B., Massonneau, Julie, Cherel, Yan, Larcher, Thibaut
Publikováno v:
Revue Française d'Histotechnologie
Revue Française d'Histotechnologie, Association française d'histotechnologie, 2010, pp.11-24
Revue Française d'Histotechnologie, Association française d'histotechnologie, 2010, pp.11-24
Le formaldéhyde, fixateur des tissus biologiques, a été classé « cancérogène de groupe I » par le Centre International de Recherche sur le Cancer (CIRC). La réglementation française impose donc sa substitution, sous condition que cela soit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::1fa1ebe1df4c0fd08e0976f1764a46ee
https://hal.inrae.fr/hal-02667357
https://hal.inrae.fr/hal-02667357
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Fovet CM; Commissariat à l'Énergie Atomique (CEA), Molecular Imaging Research Center (MIRCen), 92260 Fontenay-aux-Roses, France., Stimmer L; Commissariat à l'Énergie Atomique (CEA), Molecular Imaging Research Center (MIRCen), 92260 Fontenay-aux-Roses, France., Contreras V; CEA, INSERM, Université Paris-Sud, U1184, IDMIT Department, Fontenay-aux-Roses 92265, France., Horellou P; CEA, INSERM, Université Paris-Sud, U1184, IDMIT Department, Fontenay-aux-Roses 92265, France., Hubert A; Vacine Research Institute, INSERM U955 Institut Mondor de Recherche Biomédicale (IMRB), Créteil, France., Seddiki N; Vacine Research Institute, INSERM U955 Institut Mondor de Recherche Biomédicale (IMRB), Créteil, France., Chapon C; CEA, INSERM, Université Paris-Sud, U1184, IDMIT Department, Fontenay-aux-Roses 92265, France., Tricot S; CEA, INSERM, Université Paris-Sud, U1184, IDMIT Department, Fontenay-aux-Roses 92265, France., Leroy C; CEA, INSERM, Université Paris-Sud, U1184, IDMIT Department, Fontenay-aux-Roses 92265, France., Flament J; Commissariat à l'Énergie Atomique (CEA), Molecular Imaging Research Center (MIRCen), 92260 Fontenay-aux-Roses, France., Massonneau J; Commissariat à l'Énergie Atomique (CEA), Molecular Imaging Research Center (MIRCen), 92260 Fontenay-aux-Roses, France; Laboratoire des Biothérapies, INSERM, UMS27, F-92260 Fontenay-aux-Roses, France., Tchitchek N; CEA, INSERM, Université Paris-Sud, U1184, IDMIT Department, Fontenay-aux-Roses 92265, France., 't Hart BA; Department of Immunobiology, Biomedical Primate Research Centre (BPRC), 2280 GH Rijswijk, the Netherlands; University of Groningen, Department of Biomedical Sciences of Cells and Systems, University Medical Center, Groningen, the Netherlands., Zurawski S; Baylor Institute for Immunology Research (BIIR), Dallas, TX 75204, USA., Klucar P; Baylor Institute for Immunology Research (BIIR), Dallas, TX 75204, USA., Hantraye P; Commissariat à l'Énergie Atomique (CEA), Molecular Imaging Research Center (MIRCen), 92260 Fontenay-aux-Roses, France., Deiva K; CEA, INSERM, Université Paris-Sud, U1184, IDMIT Department, Fontenay-aux-Roses 92265, France., Zurawski G; Baylor Institute for Immunology Research (BIIR), Dallas, TX 75204, USA., Oh S; Mayo Clinic, Department of Immunology, Scottsdale, AZ 85259, USA., Le Grand R; CEA, INSERM, Université Paris-Sud, U1184, IDMIT Department, Fontenay-aux-Roses 92265, France., Serguera C; Laboratoire des Biothérapies, INSERM, UMS27, F-92260 Fontenay-aux-Roses, France; Asfalia Biologics, Institut du Cerveau et de la Moelle épinière (ICM), Hôpital Pitiè-Sâlpétrière, Paris 75013, France. Electronic address: che.serguera-y-lagache@inserm.fr.
Publikováno v:
EBioMedicine [EBioMedicine] 2019 Sep; Vol. 47, pp. 492-505. Date of Electronic Publication: 2019 Sep 03.
Autor:
Qamar Saeed M; 1] CEA, DSV, IBM, Molecular Imaging Research Center (MIRCen), Fontenay-aux-Roses, France [2] INSERM, UMS27, Fontenay-aux-Roses, France [3] Institute of Pure and Applied Biology, Microbiology Division, Bahauddin Zakariya University Multan, Pakistan., Dufour N; 1] CEA, DSV, IBM, Molecular Imaging Research Center (MIRCen), Fontenay-aux-Roses, France [2] Laboratoire des maladies neurodégénératives CNRS, CEA URA 2210., Bartholmae C; Department of Translasional Oncology, National Center for Tumor Diseases (NCT) and German Cancer Research Center (DKFZ), Heidelberg, Germany., Sieranska U; CEA, Laboratoire des Cellules Souches Hématopoïétiques et Leucémiques, (IRCM), Fontenay-aux-Roses, France., Knopf M; Department of Translasional Oncology, National Center for Tumor Diseases (NCT) and German Cancer Research Center (DKFZ), Heidelberg, Germany., Thierry E; EBIM, Ecole Normale Supérieure de Cachan, Cachan, Paris, France., Thierry S; EBIM, Ecole Normale Supérieure de Cachan, Cachan, Paris, France., Delelis O; EBIM, Ecole Normale Supérieure de Cachan, Cachan, Paris, France., Grandchamp N; NewVectys, Villebon-sur-Yvette, France., Pilet H; NewVectys, Villebon-sur-Yvette, France., Ravassard P; ICM-BBL, CNRS UMR 7225, Hôpital Pitié-Salpêtrière, Paris, France., Massonneau J; 1] CEA, DSV, IBM, Molecular Imaging Research Center (MIRCen), Fontenay-aux-Roses, France [2] INSERM, UMS27, Fontenay-aux-Roses, France., Pflumio F; CEA, Laboratoire des Cellules Souches Hématopoïétiques et Leucémiques, (IRCM), Fontenay-aux-Roses, France., von Kalle C; Department of Translasional Oncology, National Center for Tumor Diseases (NCT) and German Cancer Research Center (DKFZ), Heidelberg, Germany., Lachapelle F; 1] CEA, DSV, IBM, Molecular Imaging Research Center (MIRCen), Fontenay-aux-Roses, France [2] INSERM, UMS27, Fontenay-aux-Roses, France., Bemelmans AP; 1] CEA, DSV, IBM, Molecular Imaging Research Center (MIRCen), Fontenay-aux-Roses, France [2] Laboratoire des maladies neurodégénératives CNRS, CEA URA 2210., Schmidt M; Department of Translasional Oncology, National Center for Tumor Diseases (NCT) and German Cancer Research Center (DKFZ), Heidelberg, Germany., Serguera C; 1] CEA, DSV, IBM, Molecular Imaging Research Center (MIRCen), Fontenay-aux-Roses, France [2] INSERM, UMS27, Fontenay-aux-Roses, France.
Publikováno v:
Molecular therapy. Nucleic acids [Mol Ther Nucleic Acids] 2014 Dec 02; Vol. 3, pp. e213. Date of Electronic Publication: 2014 Dec 02.